Background: Mechanisms underlying neurodegeneration are actively sought for new therapeutic strategies. Transgenic, knockout and genetic mouse models greatly aid our understanding of the mechanisms for neuronal cell death. A naturally occurring, autosomal recessive mutant, known as wobbler, and mice transgenic for familial amyotrophic lateral sclerosis (FALS
1
) superoxide dismutase (SOD)1 mutations are available, but the molecular mechanisms remain equally unknown. Both phenotypes are detectable after birth. Wobbler is detectable in the third week of life, when homozygotes (wr/wr) exhibit prominent gliosis and significant motor neuron loss in the cervical, but not in lumbar, spinal cord segments. To address molecular mechanisms, we evaluated "death signals" associated with the multifunctional serine protease, thrombin, which leads to apoptotic motor neuronal cell death in culture by cleavage of a G-protein coupled, protease-activated receptor 1 (PAR-1). Materials and Methods: Thrombin activities were determined with chromogenic substrate assays, Western immunoblots and immunohistochemistry were performed with anti-PAR-1 to observe localizations of the receptor and anti-GFAP staining was used to monitor astrocytosis. PAR-1 mRNA levels and locations were determined by reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridizations. Cell death was monitored with in situ DNA fragmentation assays.
Results:
In preliminary studies we found a 5-fold increase in PAR-1 mRNA in cervical spinal cords from wr/wr, compared with wild-type (wt) littermates. Our current studies suggested that reactive astrocytosis and motor neuron cell death were causally linked with alterations in thrombin signaling. PAR-1 protein expression was increased, as demonstrated by immunocytochemistry and confirmed with in situ hybridization, in phenotypic wr/wr motor neurons, compared with wt, but not in astrocytes. This increase was much greater in cervical, compared with lumbar, segments, paralleling motor neuron degeneration. We also found, using reverse transcription polymerase chain reaction (qRT-PCR) with RNA from genotyped embryos, that PAR-1 was already increased in wr/wr cords at E12, the earliest time examined. Conclusions: Thus, motor neuron degeneration and death follows PAR-1 expression both temporally and topographically in wobbler mice. Since our culture studies show that thrombin mobilized [Ca
Introduction
In addition to "appropriate" apoptosis in the developing nervous system, evidence for "inappropriate" apoptosis is well-documented for a number of neurodegenerative diseases (1, 2) . In both animal and human motor neuron dis-sequent cell shrinkage leading to reduced numbers in cervical cord and brainstem. Other reports suggested much earlier detection of the phenotype (23) . Surprisingly, using profile methods, the number of motor neurons in wr/wr phrenic nerve nucleus remained relatively unchanged, compared with wt littermates, up until postnatal day 21 (P21;22). Since genotyping was unavailable, preclinical motor neuron counts were not determined and other counting methods (24, 25) were not used. High copy number FALS transgenic mice also show early vacuolar degeneration of motor neurons and fragmentation of the Golgi apparatus (7, 26) . Subsequent shrinkage of motor neurons and cell loss, changes most often seen in both sporadic amyotrophic lateral sclerosis (SALS) and FALS patients (27) , are seen in low expression SOD1 transgenic mice.
Although, in dividing cells, thrombin promotes proliferation as a growth factor, this multi-functional serine protease kills neurons in culture at nanomolar concentrations by activating the thrombin protease-activated receptor 1 (PAR-1;28-30). One laboratory reported "protection," primarily in astrocytes, at very low (pM) concentrations (28, 31) . Recent studies with mouse (32, 33) and chick (34) motor neurons, as well as rat primary hippocampal neurons (35) , have shown that apoptosis is the major mode of neuronal death, signaled through PAR-1. Earlier, we observed that PAR-1 mRNA was increased in wr/wr spinal cords (36) using a quantitative reverse transcription polymerase chain reaction (qRT-PCR) strategy. In the present experiments, we extended those observations by finding that this overexpression is concentrated in those cells bearing the disease burden, the alpha motor neurons in the cervical region. Remarkably, this up-regulation of PAR-1 is already found at the earliest time studied, embryonic day 12 (E12), more than a month before classical phenotypic detection.
Materials and Methods

Materials
Wobbler breeding pairs (NFR/N-wr/ϩ) were obtained from Drs. Carl Hanson and James Crowell (Genetic Resource Section, National Center for Research Resources, National Institutes of Health, Bethesda, MD) to establish a colony at the Kansas City Veterans Administration Medical Center's Animal Research Facility (KCVAARF), according to established orders, motor neuron death is a prominent feature, but the precise percentage of apoptosis is still uncertain. Motor neurons appear to be particularly sensitive to cell death, but over the last few years, mechanisms accounting for the selective motor neuron vulnerability and their progressive death have been difficult to define. Some information comes from studies of mutations in Cu/Zn-superoxide dismutase (SOD) (EC 1.15.1.1; SOD1), an example of apoptotic motor neuron loss. SOD1 mutations account for 20% of familial amyotrophic lateral sclerosis (FALS), which comprises 5-10% of all ALS (3-6). SOD1 transgenic mice develop amyotrophic lateral sclerosis (ALS)-like symptoms (7) through a proapoptotic "toxic gain-offunction" mechanism (8) (9) (10) . This implicates oxygen-free radical (OFR) sensitivity and greatly aids the understanding of OFR-induced damage to motor neurons (11, 12) .
The spontaneous autosomal recessive wobbler mutation, has been in active study as a model for motor neuron degeneration for more than 40 years (13) . Homozygotic wobbler mice undergo prominent, progressive motor neuron degeneration in spinal cord and brainstem (14) . This suggests their use as a model for ALS and spinal muscular atrophy (SMA), particularly infantile Werdnig-Hoffman disease (12) . Subsequently bred on many strain backgrounds, the wobbler (wr) gene was localized to proximal mouse chromosome 11 (15) , where it was tightly linked to the intronless glutamine synthase pseudogene 1 (Glns-ps1) and Rab1 (16, 17) , a GTP binding protein of the ras oncogene family. The polymorphic microsatellite marker, Glns-ps1, was previously exploited (18) by crossing ϩ/wr with New Zealand Black (NZB) mice, thereby allowing preclinical detection of the wr/wr genotype (19) (20) (21) . Preclinical detection would facilitate studies to establish precise onset of motor neuron cell death and elucidation of the responsible mechanisms.
Active expression of the wobbler phenotype was reported previously to not be detected until 3-6 weeks after birth (22) , with early vacuolar motor neuronal degeneration and sub-protocols. We obtained breeding pairs of NZB mice from Dr. Sarah Walker (VA Medical Center, Columbia, MO). All protocols were approved by the Kansas City VA Medical Center (KCVAMC) animal care and use committee and met NIH guidelines.
Polyclonal immunoglobulin G (IgG) isotype antibodies included rabbit anti-rat PAR-1 from the Robert Woods Johnson Pharmaceutical Research Institute (Spring House, PA), used at 2 g/ml; rabbit anti-human glial fibrillary acidic protein (GFAP) from Chemicon (Temecula, CA), used at a 1:2000 dilution; and rabbit anti-bovine neuron-specific enolase (NSE) from DAKO (Carpenteria, CA), used at a 1:4000 dilution. Commercial antibodies (other than those listed above), the immunohistochemistry detection system, and 3,3'-diaminobenzidine were purchased either from Biomeda (Foster City, CA) or DAKO. An avidin-biotin blocking system, biotinylated secondary antibodies, goat anti-rabbit (polyclonal antibodies), horse anti-mouse (monoclonal antibodies), and avidin-biotin-horse radish peroxidase (HRP) complex reagent, were all purchased from Vector Labs (Burlingame, CA). Antibody diluent was from Zymed Laboratories, Inc. (San Francisco, CA) and Target reagent was from DAKO. Pre-cast sodium dodecylsulfate-polyacrylamide gels (SDS-PAGE) were purchased from Novex (San Diego, CA). Nonfat dried milk and nitrocellulose membranes were obtained from Biorad (Hercules, CA) and polyvinylidene difluoride (PVDF) membranes were purchased from Millipore (Bedford, MA). The enhanced chemiluminescence (ECL) kit was purchased from Amersham (Arlington Heights, IL). PlusSuperfrost slides were from VWR (Piscataway, NJ), proteinase K from DAKO, hybridization buffer from Biomeda and Permount was from Fisher Scientific (Pittsburgh, PA). DNTPs (dCTP, dGTP, dTTP) were from Boehringer Mannheim (Indianapolis, IN), biotin-14-dATP from Gibco-BRL (Grand Island, NY), DNA polymerase I and terminal deoxynucleotidyl transferase (TdT) were from Promega (Madison, WI).
RNase H Ϫ reverse transcriptase (Superscript II), RNase inhibitor, and T7 RNA polymerase were obtained from Bethesda Research Labs (Gaithersburg, MD). RNase-free DNase I was obtained from Sigma (St. Louis, MO). Taq polymerase, Amplitaq and PCR mix was from Perkin Elmer (Norwalk, CT), and Klenow enzyme was from Boehringer Mannheim, GmbH (Mannheim, Germany). Guanidine thiocyanate/phenol reagent, Tri Reagent, was from Molecular Research Center (Cincinnati, OH), and other organic reagents were from J. T. Baker (Phillipsburg, NJ). The ⌬ Genozyme Cycle Sequencing Kit and Genomyx LR DNA gel apparatus were from Genomyx (Foster City, CA). Agarose was purchased from FMC (Rockland, ME). The in situ hybridization probes were made at Research Genetics (Huntsville, AL) and were 3'-biotinylated with Brigati Tails (six biotins in a row connected to the 3' end of the probe). The PAR-1 probe sequence was TTC ATT TTT CTC CTC CTC CTC CTC ATC.
Astrocyte Culture
Astrocytes were cultured from 28-day-old wr/wr and wt littermate whole spinal cords as described previously (37) . To obtain conditioned medium, fresh dissociated cells were plated in 80% Modified Eagle's Medium (MEM) and 20% medium 199 (both from GIBCO, Grand Island, NY) for 8 days in vitro.
PAR Antibody Production
A rabbit was immunized with a synthetic peptide corresponding to the sequence, LLSS-RVPMSQPESERC, which were identical to mouse PAR-1 residues 19-33. The peptide was coupled to keyhole limpet hemocyanin (KLH) through the C-terminal Cys and used to generate a rabbit polyclonal antibody (PAR-1C). This PAR-1C antibody was characterized previously (38, 39) and shown not to label proteins in mice lacking PAR-1 (40) .
Preparation of Tissue for Morphologic Studies
Mice were deeply anesthetized with an intraperitoneal injection of 40 l/g of a rodent cocktail [ketamine 5 mg/ml; 5% volume per volume (v/v) acepromazine in phosphatebuffered saline (PBS)] and perfused with 4 U/ml heparin in PBS. Cerebellae and spinal cords were dissected rapidly, the later separated into cervical and thoraco-lumbar regions, and placed into PBS containing freshly prepared 4% paraformaldehyde at room temperature, overnight, and embedded in paraffin. In some experiments, mice were directly perfused with 4% paraformaldehyde in PBS.
Immunohistochemistry
Wr/wr and wt tissue sections were processed together, along with negative and positive controls. They were mounted onto slides, deparaffinized, hydrated and processed for immunohistochemistry (41) . Slides were immersed in Target reagent and heated twice, for 3 min each at high power in an 800 watt commercial microwave oven. After the slides cooled down, the endogenous peroxide was blocked by 3% H 2 O 2 . Tissue slides were processed through an avidin-biotin blocking system, according to the manufacturer's instructions, and then placed in PBS. In preliminary experiments, we used human platelets as the positive control for the PAR-1C antibody.
All reagent incubations and washes were performed at room temperature. Normal blocking serum was then placed on slides for 10 min, and after a brief rinsing in PBS, primary antibodies were placed on the slides for 30 min. The slides were washed, then the biotinylated secondary antibodies, goat anti-rabbit (polyclonal antibodies), or horse anti-mouse (monoclonal antibodies) were placed on the tissue sections for 30 min. After rinsing in PBS, the avidin-biotin-HRP complex reagent was added for 30 min. The slides were washed and treated with the chromogen, 3,3'-diaminobenzidine, two times for 5 min. Then, slides were rinsed in distilled H 2 O, counterstained in Mayer's hematoxylin, dehydrated, and coverslips placed. The slides were visualized and photographed under an Olympus BX50 light microscope (Olympus, Melville, NY).
Controls were run for each sample of spinal cord tissue. Negative controls included replacement of the primary antibody with antibody diluent and the use of the same-species lgG isotype nonimmunized serum. Positive control antibodies included relevant neuronal (neuron specific enolase, NSE) and glial fibrillary acidic protein (GFAP) cellular markers. For all studies, wr/wr were always directly and simultaneously compared with their wt littermates and at least three different individuals for each genotype were analyzed.
In situ Hybridization (ISH)
Five micron tissue sections of P21 mouse spinal cords were mounted onto Plus-Superfrost slides, air dried overnight at room temperature, and processed for in situ hybridization (40) . Wr/wr and wt samples were run at the same time and positive and negative controls were always included. The slides were routinely dewaxed, then hydrated with deionized water and placed into 3% H 2 O 2 for 10 min at room temperature. After a brief wash in dH 2 O, the slides were placed into universal buffer (Research Genetics, Huntsville, AL). The tissues were digested with proteinase K for 10 min at 42ЊC. The slides were thoroughly washed and then dehydrated in 100% alcohol for 1 min. Each probe (Table 1 ) was diluted to 1.0 g/mL in hybridization buffer and then heated for 5 min at 103ЊC in a microcentrifuge tube on a heat block. The probes were placed in a 42ЊC water bath until placement onto the tissues. 10 l of probe cocktail were added to the section and a coverslip was placed over the solution. The slides were then placed in a humid chamber and incubated at 42ЊC for 2 hr. After hybridization, the slides were immediately placed into a low-stringency wash (2 ϫ SSC) for 5 min, followed by a high stringency wash (0.1 ϫ SSC) for 5 min, both at 42ЊC. Sequentially, slides were placed into universal buffer, then the avidin-HRP-biotin complex was added for 1 hr at room temperature. The slides were washed and then exposed to 3-3' diaminobenzidine twice, for 5 min each time, at room temperature. The slides were routinely stained with hematoxylin and then dehydrated, cleared in xylene, covered in Permount and photographed on an Olympus BX50 light microscope.
The positive controls included two biotinylated mRNA oligonucleotide probes; one specific to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA and the other a positive control, a poly-d(T) probe, which hybridized to poly(dA) tails on mRNAs. The negative controls included the absence of the probe in the probe cocktail and a biotinylated probe specific to lac Z operon mRNA.
Terminal Deoxynucleotidyl Transferase (TdT) Mediated Biotin-d-UTP Nick End Labeling (TUNEL) of DNA
Wr/wr and wt littermate cervical spinal cords were frozen and cryostat cut into 10 sections, fixed with formalin, permeabilized with proteinase K, and the ends were labeled with biotin-14-dATP as described (42) . TUNEL positive nuclei were visualized after incubation with HRP conjugated to streptavidin and diaminobenzidine (DAB), according to manufacturer's recommendations, and additional staining with neutral red.
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
RNA ISOLATION. For embryonic specimens, timed-dated pregnancies were established by placing two females in a male's cage at 1900 hours and observing for a vaginal plug at 0800 hours, at which time gestation was E0.5 days. At designated gestational times, pregnant females were anesthetized by CO 2 narcosis and the uterus quickly opened, embryos removed, placed in cold PBS in a sterile Petri dish, and genotypes established. Cervical and lumbar spinal cord regions were dissected and kept separate, flash-frozen in liquid nitrogen and stored at Ϫ80ЊC for further use. Frozen tissue samples (cerebellae, cervical, or lumbar spinal cord sections) were powdered using liquid nitrogen and a mortar and pestle. Then, 1 ml of Tri Reagent was added to approximately 40 mg of crushed sample and homogenized with a Polytron (on ice, three bursts of 2 sec each). The mix was incubated at room temperature for 5 min, followed by the addition of 0.2 ml of isoamyl alcohol-free chloroform, manual inversion for 15 sec, and further incubation at room temperature for 15 min. After centrifugation at 12,000 ϫ g for 15 min at 4ЊC, the aqueous phase was separated and RNA precipitated for 10 min at room temperature with 0.5 ml of isopropanol. Centrifugation at 12,000 ϫ g for 10 min at 4ЊC resulted in a pellet that was subsequently washed in 1 ml of 75% ethanol (Ϫ20ЊC). The pellet was isolated after centrifuging at 7500 ϫ g for 5 min at 4ЊC and removal of the supernatant. The RNA pellet was desiccated under vacuum, resuspended in diethylpyrocarbonate (DEPC)-treated H 2 0, quantitated by spectrophotometry (A 260 and A 280 ), and stored at Ϫ70ЊC.
Total RNA isolated from wobbler and wt littermate spinal cords was used to determine the presence of PAR-1 message by RT-PCR as follows: 0.5 g of RNA was incubated in 20 l of 50 mM KCl, 10 mM Tris HCl, pH 8.3, 1.5 mM MgCl 2 , 10 mg/ml gelatin, 1 mM dNTP, 200 U reverse transcriptase, and 0.5 M downstream, reverse primer (5'-GCCATCACCC AAATGACCAC) for 10 min at room temperature; followed by 30 min at 42ЊC, 5 min at 95ЊC, and finally cooled to 4ЊC. The cDNA produced in this RT reaction was then amplified under similar buffer conditions, except the volume was 100 l, the dNTP concentration was 0.2 M, and 0.5 M upstream, forward primer (5'-CTTGCTGATC GTCGCCCTCG) was added. The PCR was begun at 98ЊC for 10 min, followed by the addition of 2.5 U Taq polymerase, and 30 cycles of 95ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 7 min. Negative control pairs lacking only RT or lacking only template were included in each run and did not produce bands.
CO-AMPLIFICATION. PAR-1 and GAPDH cDNAs were generated simultaneously from the same reaction with 0.5-1.0 g RNA in a 20 l reaction containing 0.5 M PAR-1 reverse primer, 0.5 M GAPDH reverse primer (5'-ATCCAC-GACGGACACATTG), and the same reaction conditions for reverse transcription as above. Each standard 50 l PCR consisted of 2.5 l cDNA product, 0.5 M of PAR-1 forward and reverse primer, and 0.5 M GAPDH forward (5'-GGCAAATTCAACGGCACAG), and reverse primer. All products were viewed on a 3% Metaphor agarose gel stained with ethidium bromide.
Quantitative RT-PCR (qRT-PCR)
MIMIC RNA SYNTHESIS. A subclone, in which a deletion was introduced (pRMS11) and utilized to synthesize control/mimic RNA, was generated (36) from a pSport rat PAR-1 cDNA clone, provided by the laboratory of Marschall Runge, M.D., Ph.D (University of Texas, Medical Branch, Galveston, TX). Mimic RNA for this experiment was produced from pRMS11 linearized by digestion (with HindIII), transcribed, and quantified spectrophotometrically at 260 and 280 nm as described (36) .
Reverse transcription reactions were set up using dilutions of the generated mimic PAR-1 RNA (36), together with varying amounts of endogenous RNA as the templates in the same reactions. This coamplification, using the same primers and reaction conditions, allowed for the quantitation of the native PAR-1 message, relative to the mimic. 20-l reactions were set up and PCR was performed using 10 l of the generated cDNA. The products were visualized on a 3% Metaphor agarose gel stained with ethidium bromide.
Genotyping
In our NZB colony, the G NZB allele that is adjacent to the wobbler locus on mouse chromosome 11 (15) , produced a 188-bp amplification product when DNA was amplified with 5'-AGCTTTGGAG ACAACAATTAGATC and 5'-GGATGGGGA AATGGTGGTACA specific glns primers (18) . The glns locus in the NFR/N strain (G NFR ) yielded a 162-bp product, as did other non-NZB strains, such as CD1 (not shown). DNA was extracted from 1 cm tail snips or small liver samples (in the case of embryos) and purified with a Qiagen (Valencia, CA) tissue DNA kit. PCR amplification was performed with ϳ50 ng DNA in 100 l reactions with 0.5 M each primer, 1X PCR reaction mix, and 200 M each dNTP. The DNA was initially denatured at 98ЊC for 10 min, then 2.5 U of Taq polymerase was added at 90ЊC, followed by 30-35 cycles of denaturation at 95ЊC, for 1 min, annealing at 55ЊC, for 1 min, and extension at 72ЊC for 30 sec. Products were visualized by electrophoresis in 3% Metaphor (FMC, Rockland, ME) agarose gels and staining with ethidium bromide. For rapid genotyping, we extracted DNA from small, homogenized samples that were incubated with detergent and proteinase K for 15 min at 55ЊC and amplified with 15 sec denaturation, annealing, and extension steps according to Arce et al. (43) .
Thrombin Amidolytic Assay
Using the thrombin-preferred chromogenic substrate, S-2238 (D-Phe-Pip-Arg-p-nitroanilide) (44) , thrombin activity was measured in conditioned medium of primary murine spinal cord astrocytes from 28-day-old wt and wr/wr mice (37), kept 8 days in vitro, with the final 24 hr in serum-free condition. The release of p-nitroanilide was measured at 410 nm as previously described (45) .
SDS-PAGE and Western Blots
Wobbler and wt spinal cords were removed as above and cervical cord segments dissected, blotted dry, weighed and homogenized in a 1:10 ratio (weight per volume, w/v) of 50 mM Tris HCI (pH 7.4) containing 250 mM sucrose, 10 mM EDTA, 150 mM NaCl and 1% Triton X-100 Cord extracts were centrifuged at 15,000 ϫ g for 15 min at 4ЊC, and the supernatants were collected and analyzed for protein using the BCA method. Samples, ranging from 5-25 g, were applied to a precast 12% SDS-PAGE under reducing conditions and, then, transferred to PVDF membranes and blocked with 10% nonfat dry milk and 0.1% Tween 20 in PBS, as previously described (45) . PVDF membranes were treated with a 1:500 dilution of antibody PAR-1C in 3% nonfat dry milk and 0.1% Tween 20 in PBS, followed by HRP-conjugated goat anti-mouse IgG at the same conditions, and visualized with the ECL kit.
Statistics
Comparison of PAR-1 mRNA between wr/wr and wt littermates was performed with a twotailed, unpaired Student's t-test using StatView 4.0 software (Abacus Concepts, Berkeley, CA).
Results
Release of Thrombin from Spinal Cord Astrocytes in Culture
Prothrombin is expressed in both developing central (46) and peripheral nervous systems (47, 48) , and after neural injury (32) . In the brain, astrocytes synthesize and secrete prothrombin (49, 50) . Therefore, we first addressed the possible pathologic interactions between motor neuron cell death and the prominent astrocytosis in wr/wr mice by analyzing thrombin amidolytic activity in young adult (28-day-old) spinal cord astrocytes after 8 days in vitro, with a final 24 hr in serum-free conditions. Conditioned media (CM) was collected from wr/wr and wt littermate spinal cord astrocyte primary cultures (8 days in vitro). Amidolytic activity was assayed with a thrombin-preferred chromogenic substrate (45) and further confirmed by inhibition with hirudin, the thrombin-specific inhibitor from the leech (51) . Wr/wr glial cells released a 2-fold greater amount of thrombin amidolytic activity (7.9 Ϯ 0.5 U/mg protein), compared with wt astrocytes (4.5 Ϯ 0.7 U/mg protein; p ϭ 0.015), and more than 90% of this activity was inhibited by 100 nM hirudin. This allowed us to postulate that increased protease-ligand from astrocytes might interact with greater PAR-1 expression in motor neurons (36) .
Phenotypic Features and Reactive Astrocytosis
Unlike earlier reports in the literature (22) , wr/wr mice in our colony showed the first clinical symptoms and neurological abnormalities prior to P21. Wr/wr mice were significantly smaller than their wt littermates and this was detected by P15 when these mice first developed atrophy of forelimb muscles and shaking ("wobbling") of the body. If left undisturbed, they died by 3 to 6 months of age.
We localized GFAP in wr/wr spinal cords using immunohistochemistry with a commercial polyclonal antibody to GFAP and our re- sults confirmed two previous reports indicating that overgrowth of astrocytes accompanied motor neuronal degeneration in wobbler mice (37, 52) . Basal levels of GFAP in the white matter and extremely low levels of GFAP were detected in the gray matter of normal wt littermate spinal cords (Figs. 1A and B) . In stark contrast, a marked increase in GFAP immunolabeling was found not only in the white, but also in the gray, matter of the wobbler spinal cord (Figs. 1C  and D) .
PAR-1 Western Blots of wt and wr/wr Spinal Cord Extracts
Using a rabbit polyclonal anti-mouse PAR-1 (PAR-1C) antibody, we performed Western transfers with protein extracts of both wt and wr/wr mouse spinal cords and found that it recognized in both an ϳ50 kDa polypeptide (53,54; Fig. 2 ). This band was similar in Mr to that previously reported for mouse fibroblast PAR-1 (53) . Previous studies with model and primary motor neurons in culture, using a different antibody (R49) made against residues 36-49 of the human PAR-1 spanning the thrombin cleavage site, recognized a similar-sized, ϳ50 kDa protein (54) . As seen in the Western blots using anti-PAR-1C antibody, in addition to the ϳ50 kDa band, we detected an additional band at lower Mr (ϳ45 kDa; Fig. 2 ). No other bands were visible. The size was similar in Mr to that found in CM of NSC19 motor neurons treated with ␣-thrombin using the R49 antibody (54) . Cleavage of PAR-1 has not been examined previously in tissue extracts. However, in our studies, evidence for partial cleavage for at least some population of PAR-1 molecules was found consistently in all wobbler spinal cord extracts (we labeled this fragmented band at ϳ45 kDa, PAR-1 f ), but less in wt spinal cord samples.
Using the PAR-1C antibody, we then performed immunohistochemistry and observed that PAR-1 primarily stained large ventral horn motor neurons in spinal cords of 28-day-old wt mice (Figs. 3A and B) . Faint staining was observed over dorsal horn neurons, as well as on smaller interneurons within the ventral horns. There was little reaction found in the white matter tracts laterally or anteriorly. In stark contrast to motor and other neurons, very faint staining of non-neuronal cells was seen in either the gray or white matter of the cord. Slightly greater staining was found in sections of wt cerebellum (not shown).
In contrast to the fine, homogeneous membrane staining in wt mice, PAR-1 was found to be increased in the 28-day-old wr/wr cervical cord (Figs. 3C and D) , where we confirmed (Fig. 1 ) that the degeneration was greatest (14, 22) . The increased PAR-1 immunostaining in wr/wr spinal cords was present throughout the cervical cord gray matter in both dorsal, as well as ventral, horns. This was in contrast to the white matter, which was clearly outlined from it, where axons did not stain either in wt or in wr/wr mice (Fig. 3A) . The most dramatic cellular findings were in the large alpha motor neurons of the ventral horn. It is these cells that bear the brunt of the degeneration in the wobbler mutation (14, 22) . By this technique, we found that virtually all remaining motor neurons had markedly increased levels of PAR-1 protein. Considerably less staining, similar to the intensity range of controls, was seen in thoracolumbar sections of wr/wr mouse spinal cords, as well as in thoracolumbar regions of littermates (not shown), where a number of large neuronal profiles that were consistent with motoneurons were not stained by the anti-PAR-1 antibody.
PAR-1 Gene Expression
Normal rat motor neurons were recently shown to contain increased amounts of PAR-1 mRNA by in situ hybridization compared with other neuronal populations (55) . Pathologic increase in PAR-1 expression might make these motor neurons even more sensitive to thrombin's effects, whether locally produced (32, 46) or passing a bridged blood-brain or spinal cord barrier (28) . Since many of the remaining motor neurons in wr/wr spinal cords that stained with anti-PAR-1 antibody appeared somewhat shrunken and pyknotic, we sought confirmation of increased expression at the mRNA level. When we previously performed RT-PCR to subplateau levels, the PAR-1 message was clearly detectable in wt littermate, as well as wobbler, spinal cords (36) . However, greater amplified product was found in matched RNA samples obtained from adult wr/wr cervical cord RNA, compared with wt (Fig. 4A) . Slightly greater PAR-1 mRNA, again semiquantitative, was detected in wr cerebellar RNA, compared with normal RNA.
Given the semi-quantitative RT-PCR increase in PAR-1 mRNA in wr/wr, compared with wt, littermates (36), we compared the PAR-1 mRNA directly to GAPDH mRNA levels in the same samples (Fig. 4B) , confirming previous results with other litters (36) . When cotranscribed and amplified with primers that also amplify the sequence of the GAPDH gene, we obtained dual products from these two primer pairs at the appropriate sizes. The 660-bp PAR-1 product appeared above the 573-bp GAPDH amplimer and, when the relative intensities of the bands were quantified, the results showed that the PAR-1 message was elevated ϳ3-fold, relative to GAPDH in the wobbler spinal cord, compared with the wt littermate ( Fig. 4B; Table 2 ). Since there was some reproducible attenuation of the GAPDH amplimer in the wobbler spinal cord extracts, we tested endogenous RNAs from wr/wr and wt littermate spinal cords with in vitro generated control PAR-1 RNA.
Quantitative RT-PCR (qRT-PCR)
Using authentic and mimic templates described in "Material and Methods" and previously detailed (36), we confirmed the significant increases in PAR-1 mRNA levels. The 237-bp deletion we generated in a PAR-1 cDNA (subcloned into the pCR2.1 transcription vector) enabled qRT-PCR to accurately determine the PAR-1 mRNA content in each spinal cord. This approach previously allowed us to quantify levels of prothrombin mRNA in developing mouse muscle (47) and, recently, in rat spinal cord (Citron et al., submitted) . With the introduction of titrated amounts of control, mimic transcript into the RT reaction prior to amplification, we were able to estimate the copy number of PAR-1 mRNA present in the wr/wr spinal cords, compared with wt littermates and, more directly, to measure the increased levels of PAR-1 message. As seen in Figure 4C , relatively more PAR-1 message, relative to specific mimic RNA added, was present in wr/wr RNA samples. From calculations in Table 2 , normalization to input templates and relative product yields, indicated that the PAR-1 mRNA was greater than 5-fold higher, compared with the wt littermate (p ϭ 0.018). Of interest, correlating again with the burden of degeneration of motor neurons and increased GFAP staining (astrocytosis), the increase in PAR-1 mRNA measured by qRT-PCR was greatest in the wobbler cervical spinal cord, when compared with both cerebellum and thoracolumbar spinal cord (Fig. 5) .
PAR-1 mRNA Localization in wt and wr/wr Spinal Cords
In situ hybridization experiments produced unambiguous negative controls, such as the biotinylated lacZ operon probe (Fig. 6E,F) ; whereas, all positive controls, such as the poly d(T) biotinylated probe, labeled consistently (data not shown). These hybridizations showed that PAR-1 mRNA expression levels were consistent with both the protein and RT-PCR data. The labeling pattern in the wt spinal cord was uniform and homogenous (Fig. 6A) . Although we found minimal nuclear labeling, with negative nucleoli, there was a more defined area of perinuclear labeling. Non-neuronal cells (astrocytes and oligodendroglia) did not la-bel significantly with the PAR-1 oligoprobe (Fig. 6B) .
In clear contrast to wt littermates, the labeling pattern in wobbler spinal cords detectable by ISH was strikingly different, since it was markedly heterogeneous and nonuniform (Fig.  6C) . In addition to increased perinuclear labeling for PAR-1 mRNA in motor neurons, the nucleoplasm labeled intensely (Fig. 6D) . Neurons in wr/wr cords labeled similar in pattern to wt neurons and large motor neurons displayed prominent PAR-1 mRNA labeling (arrowheads). However, the intensity of labeling was much greater and was restricted to the largest neurons in the ventral and, to a lesser extent, dorsal, horns. At higher magnification the labeling was aggregated and overlaid motor neuron nuclei. This abnormal motor neuron labeling was most intense in the cervical regions (Fig. 3) , compared with thoracolumbar segments, as we had found for immunohistochemistry. Surprisingly, despite the increase in reactive astrocytes, their increased GFAP, and the PAR-1 increased by qRT-PCR, this increase was not detected in astrocytes by in situ hybridization.
Mode of Cell Death in wr/wr Mice
We next attempted to determine the type of cell death occurring in the wobbler cervical spinal cord regions. Examination of in situ nuclear DNA fragmentation in the earliest phenotypically apparent wobbler homozygotes revealed dramatic TUNEL-positive nuclei, indicative of apoptotic fragmentation as shown in Figure 7 . The TUNEL-positive cells were located primarily in the ventral horn and exhibited the large size, large nucleus, and other characteristics of motor neuron morphology. Of interest, in later wr/wr spinal cords (ϾP28), the percentage of apoptotic neurons in the ventral horns decreased significantly and the rapid decline in the number of motor neurons appeared to slow down (not shown). Spinal cords isolated from age-matched controls never displayed this labeling (Fig. 7) . This suggested developmental regulation of postnatal apoptosis and raised the question as to when up-regulation of PAR-1 mRNA occurred in wr/wr spinal cords.
Developmental Regulation of PAR-1 Expression in wr/wr Spinal Cords
Having confirmed our previous finding of the increase in PAR-1 expression in 28-day-old phenotypic wr/wr mice (36), this prompted us to question when this overexpression occurred in their development. By postnatal day 21, the homozygous wobbler mouse phenotypically had lost significant motor function in the forelimb Note the perinuclear, cytoplasmic pattern of labeling, lack of labeling of the nucleolus and diffuse labeling in the nucleoplasm. Astrocytes (asterisks) do not stain. Micrographs (C) at 150ϫ and (D) at 600ϫ magnification of wr/wr cervical cord show mark overexpression of PAR-1 message, which completely fills motoneurons (arrowheads) and overlies nucleus and nucleolus. Despite this, little or no PAR-1 mRNA can be detected even in wr/wr astrocytes (asterisks). As a negative control, in situ hybridization with biotinylated lac Z mRNA oligonucleotide probe did not produce any detectable hybridization in the spinal cords at 300ϫ (E) and 600ϫ (F) magnification. regions and motor neurons had been lost preferentially from the cervical region of the spinal cord (22) . To understand the processes involved in the loss of these motor neurons and to determine whether they shared any features with other known mechanisms that could result in motor neuron death, we examined PAR-1 expression prior to phenotypic expression.
To accomplish this, we turned to the powerful technique of genotyping preclinical wobbler mice, using techniques previously developed (18) . The NZB strain harbored a polymorphism in the intronless glutamine synthetase pseudogene (glns1) that was tightly linked to the wobbler (wr) locus (16) . This enabled preclinical diagnosis of the wr genotype. Since the background strain (NFR obtained from NIH) upon which our wobbler colony was bred possessed a microsatellite of the glns1 that migrated faster in agarose gels (162 bp), compared with the NZB (188 bp) mice, we backcrossed obligate preclinical wobblers with NZB and obtained informative matings in the third generation (Fig. 8) . We then obtained both DNA and RNA from embryonic (E12-18) and postnatal (P0-P45) times and performed qRT-PCR with mimic PAR-1 mRNA (36) . The results of this study are shown in Figure 9 and Table 3 . In control animals, PAR-1 was biphasic, with high to low levels in the embryonic spinal cord and a second peak during postnatal throughout development and continued at low levels in the adult. In stark contrast, wr/wr mice display elevated PAR-1 expression as early as E12 in development (Fig. 9 ), which continued at this level into adulthood, with a possible further increase (8 fold) in the early postnatal period (Table 3 ). This elevation preceded the loss of motor neurons (22) and indicated the potential involvement of PAR-1 in important early signaling events responsible for motor neuron loss.
Discussion
As a model for understanding the underlying molecular interactions that occur during neurodegeneration, studies of the wobbler mutant mouse, where cervical motor neurons are lost during the first three weeks of life and loss of motor function results, have been quite useful. Astrocytosis is prominent in wobbler spinal cords (52; Fig. 1 ), suggesting an abnormal cellular interaction involving glutamine synthetase (56) . Early on, we noted that wr/wr spinal cord astrocytes (37) resembled astrocytes exposed to thrombin (57) . Published data indicated that astrocytes were the cells responsible for production of prothrombin mRNA (49) in embryonic rat brain (46) and we first asked whether astrocytes might be producing excess thrombin in wobbler. In fact, adult wr/wr astrocytes produce greater amounts of active thrombin than their wt littermates. Since thrombin has been shown to kill motoneurons in culture by triggering the PAR-1 receptor and we previously reported increased PAR-1 message in wr/wr spinal cord RNA (36) , motoneurons might be vulnerable to "death signals" produced by astrocytes.
We now report the first demonstration of up-regulated PAR-1 expression in a spontaneous, naturally occurring disease in situ. While this manuscript was in preparation, PAR-1 overexpression in highly metastatic human breast carcinoma cell lines and biopsy specimens was reported (58) . PAR-1 expression directly affected cancer cell behavior, since PAR-1 antisense cDNA inhibited metastasis (59) . In postmitotic neurons, thrombin would not be mitogenic but is in fact, apoptogenic in these cells (28, 29, (33) (34) (35) . Indicating a role in development, PAR-1 null (-/-) mice show profound effects of the disrupted allele on embryonic survival (38, 60) . It is of interest to consider whether antisense PAR-1 oligonucleotides treatment would affect up-regulation in wobbler motoneurons and whether this would be neuroprotective against progressive motoneuron cell death.
Although the initial studies showing that thrombin-activated PAR-1 induced apoptotic cell death were performed with neurons, these were primary rat hippocampal neurons grown under stress conditions (28, 29, 35) . These cells are much less sensitive to thrombin under normal conditions (61) . In the absence of a stress stimulus, model (32, 33) and primary motor neurons (33, 34, 62, 63) are much more susceptible to thrombin's killing effects. In contrast to -/-mice, all transgenic mice overexpressing PAR-1 survive, but with behavioral abnormalities (Stevens, et al., unpublished). In the absence of CNS-targeting, clearly none of these effects are mediated via platelets, the cells originally used to clone PAR-1 (64) . In this regard, PAR-1 overexpression in wr/wr spinal cord, in Western blots, immunohistochemistry and nucleic acid studies, was greatest in cervical cord motoneurons (Figs. 2-5) , where the degeneration is most prominent ( Fig. 1; 22,65,66 ). Parallel analyses of the cerebellum or of thoracolumbar cords by these methods consistently shows that the dramatic increases in PAR-1 are restricted to the clinically affected cervical regions (Figs. 3, 5) , suggesting that tissue and inducer-specific regulators may be involved.
The results with normal wt littermates establish that PAR-1 is expressed in the mouse Table 3 .
spinal cord, as it is in the rat (55), primarily in motor neurons (50, 67, 68 Table 3 ). Strikingly, despite this marked increase of PAR-1 mRNA and marked reactive gliosis with increase in GFAP (Fig. 1) , the in situ studies fail to convincingly show increased PAR-1 expression in astrocytes (Fig. 6) . The astrocytic response to thrombin (reversal of stellation) in culture is mediated via PAR-1 (57,69), yet, this does not correlate with a PAR-1 increase in wr/wr spinal cord astrocytes in vivo. Our results do suggest, however, a pathologic interaction between wobbler astrocytes releasing thrombin and the overexpression of PAR-1 in alpha motor neurons.
Increased PAR-1 expression occurs as early as E12 ( Figure 9 and Table 3 ), peaks shortly after birth, and then declines. Collection of spinal cords from earlier time points will strengthen these observations and further allow counts of islet-1/2 positive motoneurons (24, 25) , along with islet-negative interneurons and astrocytes and apoptosis indices to establish the relationship between PAR-1 expression and motoneuron loss. The delayed onset of motor neuron loss in wobbler has led to its more recent use in the study of motor neuron cell death. Although pathologic, postnatal apoptosis has been found in other mouse mutations, (70) (71) (72) (73) , apoptosis has not been established firmly in wobbler motor neurons (73) . This is significant since both bcl-2-independent and -dependent pathways have been reported in wobbler (20) . Despite protection for developmental and injury-induced neonatal cell death, cervical cord motor neurons of bcl-2 transgenic mice crossed with wr/wr still underwent pathological cell death (21) . Thus, embryonic, experimental and pathological motor neuronal death may be separated by dependence on potentially distinct mechanisms.
As shown in Figure 7 , there are suggestions that apoptosis may be involved for some motoneurons in wr/wr mice. We found TUNEL-positive cells at earlier, but less at later, postnatal times. TUNEL-positive cells have been reported in wobbler spinal cord cells, although at P28, these apparently were not motor neurons (73) . We are now examining earlier embryonic times to more carefully re-evaluate the mechanisms of cell loss. Our own data suggest that other types of cell death, such as oncosis (74, 75) , may co-exist with apoptosis in the wobbler model (Zoubine et al., unpublished).
PAR-1 is not the gene defect in wobbler, which is located on proximal mouse chromosome 11 (15) , where it is linked both to rab1 (16) and Glns-ps1 (18) . However, the fact that PAR-1 expression follows the known degeneration burden (cervical > lumbar) noted in the literature (22, 65, 66) suggests that it plays a role in the pathogenesis of motor neuron loss. Of interest, ras genes, such as rab1, have been found in platelets (76) , as well as in neurons, where they are involved both in synaptic vesicle docking (77, 78) and in post-Golgi trafficking (79, 80) . PAR-1 (cf2r, for coagulation factor II receptor) is located on mouse chromosome 13 (81) , in a region syntenic with human 5q13-14. This is the same locus for the survival motor neuron (smn) and neuronal apoptosis inhibitor protein (naip) genes, both critical for survival and implicated in motor neuron diseases such as SMA (82) . Just what interactions these small G proteins and motor neuron survival genes have with PARs must await further studies. Regardless of this, since PAR-1 activation by thrombin induces apoptotic neuronal death (28) (29) (30) and involves small G-proteins (33, 35, 83) , these results have potential consequences for neurodegeneration. One therapeutic avenue to employ (84) might be the potential use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, so-called "statin" drugs, since they interfere with the isoprenylation of Rho (85) . We have found that they are neuroprotective in cultured motoneurons treated with thrombin and TRAP-6 (Smirnova et al, submitted) .
PAR-1 dramatically mobilizes calcium in motor neurons (54) , as it does in other cells (86) . This is closely associated with several modes of cell death (87) , including necrosis and oncosis, as well as apoptosis (74, 75, 88) . This receptor alone appears to account totally for the response to thrombin, since fibroblasts derived from PAR-1 knockout mice do not respond to thrombin signaling by calcium influx unless these cells are transfected with an exogenous human PAR-1 gene (86) . On a speculative basis, thrombin-activated PAR-1 mobilization of calcium in motor neurons might provide a death-inducing mechanism, since these cells may be especially vulnerable to increased [Ca 2ϩ ] i , due to underexpression of several calcium-binding proteins, such as calbindin and parvalbumin (89) (90) (91) . Reduced parvalbumin expression may underlie the selective vulnerability of motor neurons in ALS and other human motor neuron diseases (91, 92) . In a recent in situ hybridization study, parvalbumin, not calbindin-D28K, calretinin or calmodulin, identified ALS-resistant motor neurons (90) . This may also underscore selective vulnerability of spinal cord motoneurons in wobbler. Although reduced calcium-binding proteins have been reported in wr/wr muscle (93,94), they have not been studied in spinal cord. Since thrombin acts as an extracellular death signal to activate motor neuron intracellular cysteine proteases (caspases) which cleave various substrates involved in cellular repair (33, 34) , apoptotic execution of motoneuron cell death may progress inexorably.
In summary, our current results demonstrate that in phenotypic degenerating wr/wr spinal cord, where motor neurons are progressively lost, astrocytes produce higher levels of thrombin, compared with wild type cells. In these same cords, an antibody specific for PAR-1 shows markedly increased protein levels of this thrombin receptor on wr/wr motor neurons in the ventral horn of cervical cord segments. Based on previous results showing that thrombin is synthesized at low levels within the developing spinal cord and that it induces motor neuron death through activating PAR-1, we reported that mRNA for PAR-1 was also up-regulated in phenotypic wr/wr mice (36) . We now have found that both increased protein and mRNA expression is greater in cervical, compared with lumbar, spinal cords. This was previously shown to bear the greatest burden of disease in this model and was restricted to motor neurons (22) . These results were further supported by finding quantitatively increased levels of PAR-1 mRNA, relative to mimic controls and GAPDH message, in extracts from developing wr cervical, compared with the wild type or wr lumbar spinal regions as early as embryonic day 12.5, preceding the onset of degeneration and phenotypic findings.
These results imply a pathogenetic role for PAR-1 and thrombin protease signaling in this inherited CNS degeneration. Pathologic interaction between thrombin-releasing reactive astrocytes and motor neurons overexpressing PAR-1 may be involved in the wobbler phenotype. A potential interaction between protease signaling and motoneuron viability may depend, in part, on the PAR-1 locus with the naip and smn genes on mouse chromosome 13 and in human ALS or SMA at 5q13. Although the relevance of interaction between these genes on motoneuron survival must await future studies, similar influences of the thrombin signal transduction pathway on neuronal function and survival may also be found in human neurodegenerations, as well as in ischemic stroke and after neural injury (95) . If so, then neuroprotective signal transduction strategies (84) may, indeed, become a rational molecular approach to prevent and/or reverse such processes. 
